OL
ADMA icon

Odyssean LLC’s ADMA Biologics ADMA Stock Holding History

Odyssean LLC’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
+124,498
New +$1.13M 0.17% 208
2026
Q1 		– Sell
-31,296
Closed -$571K – 420
2025
Q4 		$571K Buy
+31,296
New +$527K 0.41% 151

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Odyssean LLC's ADMA Position: Q2 2026 in Review

Odyssean LLC opened a new position in ADMA Biologics (ADMA) in Q2 2026: 124,498 shares worth $1.04M. The stake represents 0.17% of the portfolio and ranks #208 among its holdings. This is a return to the name: Odyssean LLC previously reported a position in ADMA as recently as Q4 2025.

Odyssean LLC first reported a position in ADMA in Q4 2025 and has held it in 2 quarters since. 320 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Odyssean LLC held 124,498 shares of ADMA Biologics worth $1.04M as of Q2 2026.
  • ADMA Biologics was a new Odyssean LLC position in Q2 2026.
  • ADMA Biologics made up 0.17% of Odyssean LLC's portfolio in Q2 2026, its #208 holding.
  • Odyssean LLC first reported a position in ADMA Biologics in Q4 2025 and has held it in 2 quarters since.
  • 320 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Odyssean LLC's 13F filing for Q2 2026, filed 14 Aug 2026.